The kinin antagonist Hoe 140 reduces acute paw oedema in rats caused by carrageenan, bradykinin and kaolin

Inflammopharmacology

Volumn 6, Issue 1, 1998, Pages 9-17

  Sharma, J N ^a   Yusof, A P M ^a   Wirth, K J ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Bradykinin antagonist; Hoe 140; Inflammatory reactions; Kinins; Oedema; Rat

Indexed keywords

BRADYKININ; CARRAGEENAN; ICATIBANT; KAOLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HISTAMINE RELEASE; KALLIKREIN KININ SYSTEM; MEDIATOR RELEASE; NONHUMAN; PATHOGENICITY; PAW EDEMA; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

EID: 0031895462     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-998-0002-8     Document Type: Article

References (17)

1. 1. JN Sharma 1991 The role of kallikrein-kinin system in joint inflammatory disease Pharmacol Res 23 105 12 1648214 10.1016/S1043-6618(05)80112-4 1:CAS:528:DyaK3MXlslCksr4%3D Sharma JN. The role of kallikrein-kinin system in joint inflammatory disease. Pharmacol Res. 1991;23:105–12.
2. 2. JN Sharma 1991 The role of kinin system in joint inflammatory disease Eur J Rheumatol Inflamm 11 30 7 1365470 1:STN:280:ByqC3cvit1M%3D Sharma JN. The role of kinin system in joint inflammatory disease. Eur J Rheumatol Inflamm. 1991;11:30–7.
3. 3. JN Sharma 1992 Involvement of the kinin forming system in pathophysiology of rheumatoid inflammation Agents Actions 38 Suppl.III 343 61 1:CAS:528:DyaK3sXhsVCmtrc%3D Sharma JN. Involvement of the kinin forming system in pathophysiology of rheumatoid inflammation. Agents Actions. 1992;38(Suppl.III):343–61.
4. 4. JN Sharma 1993 Therapeutic prospects of bradykinin receptor antagonists Gen Pharmacol 24 267 74 8387049 1:CAS:528:DyaK3sXktVWjsbg%3D Sharma JN. Therapeutic prospects of bradykinin receptor antagonists. Gen Pharmacol. 1993;24:267–74.
5. 5. JN Sharma SSJ Mohsin 1990 The role of chemical mediators in the pathogenesis of inflammation with emphasis on the kinin system Expl Pathol 38 73 96 1:CAS:528:DyaK3cXlsV2lt70%3D Sharma JN, Mohsin SSJ. The role of chemical mediators in the pathogenesis of inflammation with emphasis on the kinin system. Expl Pathol. 1990;38:73–96.
6. 6. JN Sharma WW Buchanan 1979 Kinin system in clinical and experimental rheumatoid inflammation Curr Med Res Opin 6 314 21 396108 1:CAS:528:DyaL3cXht1Kht7Y%3D Sharma JN, Buchanan WW. Kinin system in clinical and experimental rheumatoid inflammation. Curr Med Res Opin. 1979;6:314–21.
7. 7. JN Sharma WW Buchanan 1994 Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease Exp Toxicol Pathol 46 421 33 7703672 1:CAS:528:DyaK2MXkt1Cltb0%3D Sharma JN, Buchanan WW. Pathogenic responses of bradykinin system in chronic inflammatory rheumatoid disease. Exp Toxicol Pathol. 1994;46:421–33.
8. 8. RJ Vavrek JM Stewart 1985 Competitive antagonists of bradykinin Peptide 6 161 4 1:CAS:528:DyaL2MXkvFyrt70%3D Vavrek RJ, Stewart JM. Competitive antagonists of bradykinin. Peptide. 1985;6:161–4.
9. 9. K Wirth FJ Hock U Albus 1991 Hoe 140 a new potent and long acting bradykinin antagonist — in vivo studies Br J Pharmacol 102 774 7 1364852 1:CAS:528:DyaK3MXhslyqsbc%3D Wirth K, Hock FJ, Albus U et al. Hoe 140 a new potent and long acting bradykinin antagonist — in vivo studies. Br J Pharmacol. 1991;102:774–7.
10. 10. JM Stewart L Gera W Hanson 1996 A new generation of bradykinin antagonists Immunopharmacology 33 51 60 8856115 10.1016/0162-3109(96)00084-7 1:CAS:528:DyaK28XktVyitLg%3D Stewart JM, Gera L, Hanson W et al. A new generation of bradykinin antagonists. Immunopharmacology. 1996;33:51–60.
11. 11. JN Sharma KJ Wirth 1996 Inhibition of rats adjuvant arthritis by a bradykinin antagonist Hoe 140 and its influence on kallikreins Gen Pharmacol 27 133 6 8742510 10.1016/0306-3623(95)00078-X 1:CAS:528:DyaK28XhsVKmtLk%3D Sharma JN, Wirth KJ. Inhibition of rats adjuvant arthritis by a bradykinin antagonist Hoe 140 and its influence on kallikreins. Gen Pharmacol. 1996;27:133–6.
12. 12. JN Sharma JN Sharma 1977 Comparison of the anti-inflammatory activity of commiphora mukal (an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant Arzneimittel Forschung 27 1455 7 578471 1:STN:280:CSiB28npt1Q%3D Sharma JN, Sharma JN. Comparison of the anti-inflammatory activity of commiphora mukal (an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant. Arzneimittel Forschung. 1977;27:1455–7.
13. 13. S Wong SJ Lee MR Frierson 1992 Anti-arthritic profile of BF-389-9 — a novel anti-inflammatory agent with low ulcerogenic liability Agents Actions 37 90 8 1456184 10.1007/BF01987895 1:CAS:528:DyaK38XmtVCktbg%3D Wong S, Lee SJ, Frierson MR et al. Anti-arthritic profile of BF-389-9 — a novel anti-inflammatory agent with low ulcerogenic liability. Agents Actions. 1992;37:90–8.
14. 14. M DiRosa JP Giroud DA Willoughby 1971 Studies of the mediators of acute inflammatory response induced in rats in different sites by carrageenan and turpentine J Pathol 104 15 29 10.1002/path.1711040103 1:CAS:528:DyaE38XktFyqug%3D%3D DiRosa M, Giroud JP, Willoughby DA. Studies of the mediators of acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Pathol. 1971;104:15–29.
15. 15. M DiRosa DA Willoughby 1971 Screens for anti-inflammatory drugs J Pharm Pharmacol 23 297 8 1:CAS:528:DyaE3MXktVeksrs%3D DiRosa M, Willoughby DA. Screens for anti-inflammatory drugs. J Pharm Pharmacol. 1971;23:297–8.
16. 16. RM Burch C DeHaas 1990 A bradykinin antagonist inhibits carrageenan edema in rats Naunyn-Schmiedeberg’s Arch Pharmacol 342 189 93 10.1007/BF00166963 1:CAS:528:DyaK3cXlvVGgsrc%3D Burch RM, DeHaas C. A bradykinin antagonist inhibits carrageenan edema in rats. Naunyn-Schmiedeberg’s Arch Pharmacol. 1990;342:189–93.
17. 17. AH Costello KM Hargreaves 1989 Suppression of carrageenan-induced hyperalgesia, hyperthermia and edema by a bradykinin antagonist Eur J Pharmacol 171 259 63 2482813 10.1016/0014-2999(89)90118-0 1:CAS:528:DyaK3cXkvVCntw%3D%3D Costello AH, Hargreaves KM. Suppression of carrageenan-induced hyperalgesia, hyperthermia and edema by a bradykinin antagonist. Eur J Pharmacol. 1989;171:259–63.